Proto Labs, Inc. — FY 2015 Form 10-K
Reporting period: Fiscal year ended December 31, 2015. This annual filing also reports unaudited fourth-quarter results. Proto Labs is an online, technology-enabled manufacturer of custom parts using injection molding, CNC machining and 3D printing.
Key financial results
| Metric | FY 2015 | FY 2014 | Change |
|---|---|---|---|
| Revenue | $264.1 million | $209.6 million | +26.0% |
| Gross profit / margin | $154.4 million / 58.5% | $128.4 million / 61.3% | Margin down 2.8 percentage points |
| Operating income / margin | $67.1 million / 25.5% | $60.5 million / 28.9% | Income +10.9%; margin down 3.4 points |
| Net income / net margin | $46.5 million / 17.6% | $41.6 million / 19.9% | Income +11.7%; margin down 2.3 points |
| Diluted EPS | $1.77 | $1.60 | +10.6% |
| Operating cash flow | $58.6 million | $57.2 million | +$1.3 million |
Fourth quarter: Revenue was $73.8 million versus $56.1 million in Q4 2014; operating income was $16.6 million versus $14.7 million; net income was $12.0 million versus $10.2 million; diluted EPS was $0.45 versus $0.39.
Revenue mix and growth: Injection molding generated $163.4 million (61.8% of revenue, +16.5%); CNC machining $74.4 million (28.2%, +24.1%); 3D printing $25.1 million (9.5%, up from $9.4 million). U.S. revenue was $194.1 million (+24.4%) and international revenue $70.0 million (+30.8%), or 26.5% of total revenue. Foreign exchange reduced international revenue by an estimated $7.5 million year over year. The company served 27,235 unique product developers and engineers, up 26%; approximately 85% of revenue came from existing customers.
Cash, liquidity and debt: Cash and cash equivalents were $47.7 million; short- and long-term marketable securities totaled $98.0 million. Working capital was $111.7 million. Total liabilities were $33.4 million and shareholders’ equity was $327.6 million. No debt remained at year-end; the remaining capital-lease balance was paid in December. Operating cash flow of $58.6 million was below net investing outflows of $63.6 million, including $44.4 million of property and equipment purchases and $5.0 million net cash paid for Alphaform. Management said cash and expected operating cash flow would cover anticipated requirements for at least 12 months.
Material changes versus prior year
- Revenue growth was broad-based, with a sharp increase in 3D-printing revenue, reflecting FineLine’s contribution and the October 2015 Alphaform acquisition.
- Gross margin declined from 61.3% to 58.5%. Management attributed the decline to lower-margin 3D printing and Alphaform revenue, underutilized added capacity, and foreign-exchange effects.
- Operating expenses increased 28.6% to $87.3 million, led by higher marketing and sales and general and administrative costs. Operating income grew more slowly than revenue.
- Capital investment remained substantial: property and equipment purchases were $44.4 million, compared with $43.5 million in 2014.
- Alphaform was acquired through insolvency proceedings for $5.0 million net cash consideration and produced a $0.3 million bargain-purchase gain. Its results represented about 2% of 2015 revenue; management excluded its internal controls from the year-end controls assessment following the recent acquisition.
Outlook, commentary and risks
- No specific revenue or earnings guidance was provided. Management expects continued investment in personnel, technology, sales and marketing, factory space and equipment; it expects operating expenses to rise and cost of revenue to increase in absolute dollars. It estimated future growth capital expenditures, excluding buildings and maintenance, at approximately 8%–12% of annual revenue.
- Key risks include competition and rapid technology change; the ability to maintain turnaround time, pricing and quality; scaling operations and capacity efficiently; and integrating acquisitions. Lower-margin product mix or unused capacity could pressure margins.
- International operations expose results to currency movements. The company had no foreign-currency hedges and said a hypothetical 10% adverse exchange-rate change could materially affect operating results, though not financial position.
- Other disclosed exposures include manufacturing or IT interruptions, cybersecurity and customer-design confidentiality, reliance on limited-source suppliers, product-liability and intellectual-property claims, tax examinations, and global economic conditions. Management said it knew of no litigation expected to have a material adverse effect.
- The Alphaform acquisition was not included in management’s internal-control assessment; the auditor likewise excluded Alphaform, representing approximately 6% of assets and 2% of revenue. The company’s assessed controls were deemed effective, and the financial-statement audit opinion was unqualified.
Important facts for investors to verify
- Whether revenue growth can continue while recovering the 2015 gross-margin decline, particularly as 3D printing and acquired operations expand.
- Utilization and returns on recent capacity spending, and the expected pace of future capital expenditures.
- Organic growth and profitability by product line, separated from acquisition contributions where disclosed.
- Cash conversion and working-capital needs, including the increase in accounts receivable and inventory during 2015.
- Progress integrating Alphaform and the planned inclusion of its controls in future assessments.
- Foreign-exchange sensitivity, unhedged exposure, and the potential effect of tax and other contingencies.